title: When is it appropriate to stop antiplatelet therapy in a patient with a drug-eluting stent prior to noncardiac surgery? IMPACT consults. Proceedings of the 2nd Annual Cleveland Clinic Perioperative Medicine Summit.
authors.affiliation: Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic, Cleveland, OH 44195, USA. rajamaa@ccf.org
authors.forename: Anitha
authors.initials: A
authors.lastname: Rajamanickam
authors.forename: Vaishali
authors.initials: V
authors.lastname: Singh
authors.forename: Ashish
authors.initials: A
authors.lastname: Aneja
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control; D006801:Humans; D007431:Intraoperative Complications / Q000517:prevention & control; D019990:Perioperative Care; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D011183:Postoperative Complications / Q000517:prevention & control; D012306:Risk; D015607:Stents; D013514:Surgical Procedures, Operative
chemical_list: D010975:Platelet Aggregation Inhibitors